Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies

Part of paid clinical trials in Lutherville, Maryland.

Sponsor
BioSensics
Study ID
NCT07240805
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Dementia With Lewy Bodies (DLB)
  • Lewy Body Dementia (LBD)
  • Lewy Body Disease
  • PSP
  • Progressive Supranuclear Palsy(PSP)

Eligibility Criteria

Sex
ALL
Age
40 Years - 89 Years
Healthy Volunteers
Not accepted

Study Details

Progressive supranuclear palsy (PSP), mild cognitive impairment with Lewy bodies (MCI-LB), and Dementia with Lewy Bodies (DLB) are severe neurodegenerative diseases that cause significant motor impairment impacting daily function. Researchers at BioSensics, Johns Hopkins School of Medicine, Massachusetts General Hospital and their collaborators aim to conduct an analytical and clinical validation of wearable-based digital health technologies for monitoring upper and lower limb function in PSP, MCI-LB and DLB that could enable frequent, at-home monitoring and be incorporated into future clinical trials.

Key Dates

Start date
Jun 15, 2026
Status verified
Nov 2025
Primary completion
Jul 1, 2028
Completion
Jan 1, 2029

Study Design

Enrollment
60 participants (estimated)

Arms

  • Arm: Progressive Supranuclear Palsy (PSP)
    30 patients meeting clinical diagnostic criteria for probable Progressive Supranuclear Palsy will be recruited for the study
  • Arm: Dementia with Lewy Bodies (DLB) and Mild Cognitive Impairment with Lewy Bodies (MCI-LB)
    30 patients meeting clinical diagnostic criteria for probable MCI-LB or DLB will be recruited into the study

Primary Outcome Measure

2-Minute Walk Test (2MWT) [ Time Frame: Baseline. ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Johns Hopkins University School of MedicineLuthervilleMaryland21093
Hannah Jackson
[email protected]
4235304157
Alexaner Pantelyat, MD (PRINCIPAL_INVESTIGATOR)
Massachusetts General HospitalBostonMassachusetts02114
Jesse Wang
[email protected]
617-643-2400
Anne-Marie Wills, MD, MPH (PRINCIPAL_INVESTIGATOR)

Find similar trials in Lutherville, MD

By research site
Johns Hopkins University School of Medicine· Lutherville, MDMassachusetts General Hospital· Boston, MA

Related Studies